Molkem delivers high-quality Active Pharmaceutical Ingredients (APIs) from WHO-GMP, ANVISA, EU GMP, and USFDA-approved facilities. We specialize in tailored API solutions, offering flexibility from small-batch to large-scale production while adhering to the highest global regulatory standards.
Our end-to-end regulatory support includes DMF filings (CEP, US-DMF, CADIFA), Tech Packs, Stability Studies, and strict compliance with pharmacopeial quality parameters ensuring seamless integration into your pharmaceutical processes.
With a strong commitment to responsible sourcing, full traceability, and patent non-infringing routes, we enable our customers to bring products to market faster and with greater confidence. At Molkem, quality, transparency, and customer satisfaction are at the heart of our operations, making us your trusted partner in the global pharmaceutical supply chain.
| APIs | CAS No | Therapeutic Segment | Chemical Formula | Specification | GMP | DMF | USFDA | EDQM | |
|---|---|---|---|---|---|---|---|---|---|
| Cadazolid | 1025097-10-2 | Anti Bacterial | C29H29F2N3O8 | In House |
|
T/P |
|
|
|
| Atazanavir | 198904-31-3 | Treatment of HIV | C38H52N6O7 | In House |
|
|
|
|
|
| Balofloxacin | 127294-70-6 | Antibacterial | C20H24FN3O4 | In House |
|
|
|
||
| Bempedoic Acid | 738606-46-7 | Antilipemic | C19H36O5 | NA |
|
|
|
|
|
| Benfotiamine | 22457-89-2 | Dietary Supplement | C19H23N4O6PS | In House |
|
T/P |
|
||
| Betahistine Mesilate | 54856-23-4 | Treatment of Ménière’s syndrome | C8H12N2.2CH4O3S | BP / EP / JP |
|
|
|||
| Brivaracetam | 357336-20-0 | Anticonvulsant | C11H20N2O2 | NA |
|
|
|
|
|
| Capsaicin | 404-86-4 | Analgesic | C18H27NO3 | NA |
|
|
|
|
|
| Carbinoxamine | 486-16-8 | Anti Allergic | C16H19ClN2O | In House |
|
|
|||
| Carisoprodol | 78-44-4 | Anti Hypertensive | C12H24N2O4 | USP |
|
|
|||
| Carvedilol | 72956-09-3 | Anti Hypertensive | C24H26N2O4 | BP / EP / USP / IP |
|
|
|
|
|
| Carvedilol Phosphate | 610309-89-2 | Anti Hypertensive | C24H26N2O4.H2O.H3O4P | In House |
|
T/P |
|
|
|
| Cetilistat | 282526-98-1 | Anti Obesity | Anti Obesity | In House |
|
T/P |
|
|
|
| Chlorhexidine Base / Digluconate 20% | 55-56-1 | Anti Septic | C22H30Cl2N10 | BP / EP / USP |
|
|
|||
| Chlorzoxazone | 95-25-0 | Muscle Relaxant | C7H4ClNO2 | USP |
|
|
|||
| Choline Dihydrogen Citrate | 77-91-8 | Lipotropic Agent | C6H7O7.C5H14NO | USP – NF |
|
|
|||
| Cinitapride Hydrogen Tartrate | 66564-14-5 | Anti Emetic | C21H30N4O4 | In House |
|
|
|
||
| Citalopram Hydrobromide | 59729-32-7 | Anti Depressant | C20H22BrFN2O | EP/IP/USP |
|
|
|
|
|
| Clomifene citrate | 50-41-9 | Infertility | C32H36ClNO8 | In House | |||||
| Coumarin | 91-64-5 | Anticoagulant | C9H6O2 | In House | |||||
| Dabigatran Etexilate Mesylate | 872728-81-9 | Anti Thrombotic | C34H41N7O5.CH4O3S | In House |
|
|
|||
| Dapagliflozin | 461432-26-8 | Anti Diabetic | C21H25ClO6 | In House |
|
T/P |
|
|
|
| Dapoxetine Hydrochloride | 119356-77-3 | Premature Ejaculation | C21H23NO | In House / IP |
|
T/P |
|
|
|
| Deferasirox | 201530-41-8 | Iron Chelator | C21H15N3O4 | In House |
|
|
|
|
|
| Dextromethorphan | 125-71-3 | Antitussive | C18H25NO | BP / EP / USP |
|
|
|
||
| Diacerein | 13739-02-1 | Osteoarthritis | C19H12O8 | NA |
|
|
|
||
| Diltiazem | 42399-41-7 | Anti Hypertensive | C22H26N2O4S | BP / EP / USP / IP / In House |
|
|
|
||
| DL Methionine | 59-51-8 | Amino Acid | C5H11NO2S | BP / EP |
|
|
|||
| Docosanol | 661-19-8 | Antiviral | C22H46O | NA |
|
|
|
|
|
| Donepezil HCl | 110119-84-1 | Anti-Alzheimer’s Disease | C24H30ClNO3 | NA |
|
|
|
||
| Dronedarone Hydrochloride | 141625-93-6 | Anti Arrhythmic | C31H44N2O5S.ClH | In House / USP |
|
|
|
|
|
| Duloxetine Hydrochloride | 136434-34-9 | Anti Depressent | C18H20ClNOS | BP / EP / USP |
|
|
|
||
| Edaravone | 89-25-8 | Treatment of Lateral Sclerosis | C10H10N2O | In House |
|
T/P |
|
|
|
| Efinaconazole | 164650-44-6 | Anti Fungal | C18H22F2N4O | In House |
|
|
|
|
|
| Adapalene | 106685-40-9 | Antiacne | C28H28O3 | NA |
|
|
|
|
|
| Adiphenine Hydrochloride | 50-42-0 | Local Anasthetic | C20H25NO2.ClH | In House |
|
T/P |
|
|
|
| Agomelatine ( Form I & Premix ) | 138112-76-2 | Anti Depressant | C15H17NO2 | In House |
|
|
|
|
|
| Albendazole | 54965-21-8 | Anti Helmintic | C12H15N3O2S | BP / EP / USP |
|
|
|
|
|
| Alfuzosin Hydrochloride | 81403-68-1 | Anti Hypertensive | C19H28ClN5O4 | BP / EP / USP |
|
|
|
||
| Alizapride | 59338-93-1 | Gastroprokinetic | C16H21N5O2 | In House |
|
|
|
|
|
| Allopurinol | 315-30-0 | Central Nervous Stimulant | C5H4N4O | BP / EP / USP |
|
|
|
|
|
| Almotriptan Malate | 181183-52-8 | Anti Migraine | C21H31N3O7S | USP |
|
T/P |
|
|
|
| Alogliptin | 850649-61-5 | Central Nervous Stimulant | C18H21N5O2 | EP / USP |
|
|
|
|
|
| Aminocaproic Acid | 60-32-2 | Control Bleeding | C6H13NO2 | NA |
|
|
|
|
|
| Amisulpride | 71675-85-9 | Anti Psychotic | C17H27N3O4S | BP / EP / USP |
|
|
|
||
| Amlodipine Besylate | 111470-99-6 | Anti Hypertensive | C26H31ClN2O8S | EP/ IP/USP |
|
|
|||
| Amorolfine | 67467-83-8 | Antifungal | C21H35NO | NA |
|
|
|
|
|
| Apixaban | 503612-47-3 | Anti Thrombotic | C25H25N5O4 | In House |
|
|
|
|
|
| Aprepitant | 170729-80-3 | Anti Emetic | C23H21F7N4O3 | In House |
|
|
|
|
|
| Aripiprazole | 129722-12-9 | Anti Psychotic | C23H27Cl2N3O2 | BP / EP / USP / IP / In House |
|
|
|
||
| Atracurium Besylate | 64228-81-5 | Muscle Relaxant | C65H82N2O18S2 | US P /BP / IP |
|
|
|
|
|
| Atropine Sulfate | 55-48-1 | Antimuscarinic agent | 2C17H23NO3.H2O4S | USP/EP |
|
|
|||
| Azacitidine | 320-67-2 | Anti Neoplastic | C8H12N4O5 | IP / IH |
|
|
|
|
|
| Azelaic Acid | 123-99-9 | Skin treatment | C9H16O4 | EP |
|
|
|
|
|
| Azilsartan Medoxomil Potassium Salt | 863031-24-7 | Anti Hypertensive | C30H25KN4O8 | In House |
|
|
|||
| Bazedoxifene | 198481-32-2 | Prevention of Postmenopausal Osteoporosis | C30H34N2O3 | In House |
|
T/P |
|
|
|
| Benzetimide HCl | 5633-14-7 | Anti cholinergic | C23H27ClN2O2 | NA |
|
|
|
||
| Benznidazole | 22994-85-0 | Antiprotozoals | C12H12N4O3 | NA |
|
|
|
|
|
| Besifloxacin Hydrochloride | 405165-61-9 | Anti Bacterial | C19H22Cl2FN3O3 | NA |
|
|
|
|
|
| Betahistine Dihydrochloride | 5579-84-0 | Treatment of Ménière’s syndrome | C8H14Cl2N2 | BP / EP / USP / IP |
|
|
|||
| Betaine | 107-43-7 | Reduce homocysteine | C5H11NO2 | USP |
|
|
|
|
|
| Bilastine Form I & Form II | 202189-78-4 | Anti Histamine | C28H37N3O3 | In House |
|
|
|
|
|
| Biperiden Hydrochloride | 1235-82-1 | Muscarinic antagonist | C21H30ClNO | In House |
|
T/P | |||
| Bisoprolol | 325.44304 | Anti Hypertensive | C18H31NO4 | BP / EP / USP |
|
|
|
|
|
| Bortezomib | 179324-69-7 | Anti cancer | C19H25BN4O4 | IP / IH |
|
|
|
|
|
| Brexpiprazole | 913611-97-9 | Anti Depressant | C25H27N3O2S | In House |
|
|
|
|
|
| Brimonidine Tartrate | 70359-46-5 | Anti Glaucoma | C15H16BrN5O6 | In House |
|
|
|
|
|
| Cabergoline | 81409-90-7 | Dopamine receptor agonists | C26H37N5O2 | EP |
|
|
|||
| Calcipotriol | 112828-00-9 | Vitamin D Derivative | C27H40O3 | EP/BP |
|
|
|||
| Calcium L-5-Methyltetrahydrofolate | 151533-22-1 | Folic Acid Supplement | C20H27CaN7O6 | USP |
|
|
|||
| Capecitabine | 154361-50-9 | Anti Neoplastic | C15H22FN3O6 | USP / IP / Ph.Eur |
|
|
|
|
|
| Carbamazepine | 298-46-4 | Anti Convulsant | C15H12N2O | BP / EP / USP |
|
|
|||
| Carbidopa | 38821-49-7 | Anti Parkinson | C10H16N2O5 | EP /USP |
|
|
|
||
| Carbimazole | 22232-54-8 | Antihyperthyroidism | C7H10N2O2S | NA |
|
|
|
|
|
| Cariprazine HCl | 1083076-69-0 | Anti Psychotic | C21H33Cl3N4O | In House |
|
|
|
||
| Cetirizine | 83881-51-0 | Anti-histamines | C21H25ClN2O3 | BP / EP / USP |
|
UD |
|
||
| Cevimeline | 124620-88-8 | Sjögren’s syndrome (Dry mouth) | C10H17NOS | NA |
|
|
|
|
|
| Chlorothiazide Sodium | 7085-44-1 | Diuretic | C7H5ClN3NaO4S2 | NA |
|
|
|
|
|
| Chlorthalidone | 77-36-1 | Antihypertensive | C14H11ClN2O4S | NA |
|
|
|
|
|
| Cilostazol | 73963-72-1 | Anti Platlet | C20H27N5O2 | USP / IP /JP |
|
|
|
||
| Citicoline | 33818-15-4 | Anti – Alzheimer | C14H27N4NaO11P2 | In House |
|
|
|
||
| Daclatasivir Dihydrochloride | 1009119-65-6 | Treatment of Hepatitis C | C40H50N8O6.2(HCl) | In House |
|
T/P |
|
||
| Deutetrabenazine | 1392826-25-3 | CNS Agent | C19H27NO3 | NA |
|
|
|
|
|
| Dex Lansoprazole | 138530-94-6 | Anti Ulcerative | C16H14F3N3O2S | In House / IP |
|
|
|
||
| Dex Rabeprazole | 171440-18-9 | Anti Ulcerative | C18H22N3NaO3S | In House |
|
|
|
||
| Dexmedetomidine | 113775-47-6 | Sedative | C13H16N2 | NA |
|
|
|
|
|
| Divalproex Sodium | 76584-70-8 | Anticonvulsant | C8H17NaO2 | BP / EP / USP |
|
|
|
||
| Dorzolamide Hydrochloride | 130693-82-2 | Glaucoma Treatment | C10H17ClN2O4S3 | In House |
|
|
|||
| Doxazosin Mesylate | 77883-43-3 | Anti Hypertensive | C24H29N5O8S | BP / EP / USP |
|
|
N |
|
|
| Doxycycline Hyclate | 24390-14-5 | Antibiotic | C24H33ClN2O10 | NA |
|
|
|
|
|
| Doxycycline Monohydrate | 17086-28-1 | Antibiotic | C22H26N2O9 | NA |
|
|
|
|
|
| Ebastine | 90729-43-4 | Anti-histamine | C32H39NO2 | In-House/IP/BP/EP |
|
T/P |
|
||
| Eberconazole Mononitrate | 130104-32-4 | Anti Fungal | C18H15Cl2N3O3 | NA |
|
T/P |
|
|
|
| Edoxaban Tosylate | 480449-71-6 | Anticoagulant | C31H38ClN7O7S2 | In House |
|
|
|
|
Molkem`s extensive network of API contract manufacturing companies allows us to offer tailored solutions that meet the specific needs of our clients. Whether you`re in need of small-batch APIs or large-scale production, we ensure that each product is manufactured to the highest quality standards and delivered with unmatched reliability. Our collaboration with industry-leading API suppliers means that we can provide flexible and scalable manufacturing options, ensuring that your pharmaceutical products are always on time and in compliance with global regulatory requirements. As a trusted API distributor, Molkem is dedicated to supporting the pharmaceutical industry with innovative and cost-effective API solutions.
In addition to our robust distribution services, Molkem offers comprehensive support throughout the product lifecycle. Our technical team works closely with API raw material suppliers and manufacturers to ensure that each ingredient is optimized for performance in your specific formulations. We also provide extensive regulatory and technical documentation to facilitate smooth regulatory submissions and market entry. Molkem`s commitment to quality, innovation, and customer satisfaction sets us apart as a leading active pharmaceutical ingredient distributor. We are here to help you navigate the complexities of API sourcing and ensure that your pharmaceutical products achieve the highest standards of excellence.
Products under valid patents shall not be offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. Customers should make their independent evaluation of the patent scenario for their respective markets and shall be responsible for all patent related liabilities.
